Merck
所有图片(3)

文件

NXF-10

Millipore

Natrix® Q 小试装置

登录查看公司和协议定价

别名:
Natrix® Q膜吸附器
eCl@ss:
32011308

ligand

quaternary amine

质量水平

描述

Natrix® Q Pilot

产品线

Natrix®

参数

75-375 mL/min flow rate

床高度

0.5 mm

柱床体积

15 mL

基质活性基团

Macroporous polymer

孔径

0.4 μm pore size

容量

3 g binding capacity (BSA)(per device)

分离技术

strong anion exchange

运输

ambient

正在寻找类似产品? Visit 产品对比指南

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
NXF-20NXF-50NATQ02525
Natrix® Q 小试装置

NXF-10

Natrix® Q 小试装置

Natrix® Q Process 150

NXF-20

Natrix® Q Process 150

Natrix® Q工艺600

NXF-50

Natrix® Q工艺600

capacity

3 g binding capacity (BSA)(per device)

capacity

23 g binding capacity (BSA)(per device

per device)

capacity

92 g binding capacity (BSA)(per device)

capacity

-

parameter

75-375 mL/min flow rate

parameter

0.6-3 L/min flow rate

parameter

2.3-11.5 L/min flow rate

parameter

6-10 mL/min water flow rate (at 15 psi)

pore size

0.4 μm pore size

pore size

0.4 μm pore size

pore size

0.4 μm pore size

pore size

0.4 μm (nominal)

ligand

quaternary amine

ligand

quaternary amine

ligand

quaternary amine

ligand

-

product line

Natrix®

product line

Natrix®

product line

Natrix®

product line

-

一般描述

Strong anion exchange chromatography membrane design to purify biomolecules with a high density of quaternary amine ligand the enables fast flow rates and high throughput at high loads while maintaining excellent impurity reduction
With a revolutionary three-dimensional macroporous hydrogel structure that provides a high density of binding sites and rapid mass transfer, Natrix®(Q)chromatography membranes deliver binding capacity that exceeds resin-based columns with fast flow rates typical of traditional membrane adsorbers.This combination of performance and speed in a single-use, plug-and-play device format enables low-risk, scalable solutions for efficient biomolecule purification.

Natrix®(Q)chromatography membrane is a high productivity strong anion exchange membrane designed for biomolecule purification. The unique Natrix®(Q)chromatography membrane is a porous polyacrylamide hydrogel containing a high density of pendant quaternary ammonium(Q) binding groups that are directly polymerized within the an inert, macroporous membrane scaffold. The interconnected pore structure and high functional group density enables fast flow rates (seconds of residence time) with impressive throughput to extremely high loads while maintaining excellent impurity reduction across a wide range of buffer conditions. The Natrix®(Q)chromatography membrane design delivers improvements in productivity, flexibility, and process robustness and economics for any bioprocess design. The Natrix®(Q) Pilot is an intermediate scale device, intended to verify and adjust operating parameters. The Pilot may be used for small-scale clinical and commercial manufacturing.
mAb nominal polishing capacity: 150 g

Membrane configuration: Pleated

1 device per package

特点和优势

Natrix® Q membrane adsorber provides users with:

  • High density of quaternary amine binding sites enabling rapid mass transfer
  • High binding capacity even at fast flow rates
  • Combination of performance and speed in, single use, plug-and-play device format enables low risk, scalable solutions for efficient biomolecule purification.

包装

Double bagged

法律信息

NACONNECT is a trademark of Merck KGaA, Darmstadt, Germany
NATRIFLO is a trademark of Merck KGaA, Darmstadt, Germany
NATRIX is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

为方便起见,与您过往购买产品相关的文件已保存在文档库中。

访问文档库

难以找到您所需的产品或批次号码?

在网站页面上,产品编号会附带包装尺寸/数量一起显示(例如:T1503-25G)。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题?欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ (Lot或Batch)字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等,请输入去除前两位字母的批号:09019TO。

  • 如果您查询到的批号含有填充代码(例如05427ES-021),请输入去除填充代码-021的批号:05427ES。

  • 如果您查询到的批号含有填充代码(例如 STBB0728K9),请输入去除填充代码K9的批号:STBB0728。

未找到您寻找的产品?

部分情况下,可能未在线提供COA。如果搜索不到COA,可在线索取。

索取COA

Mochao Zhao et al.
Vaccine, 37(36), 5491-5503 (2018-04-09)
Affinity chromatography is among the most powerful separation techniques, achieving the finest separation with high yields even in the most challenging feed streams. Incorporating affinity chromatography in vaccine purification has long been attempted by researchers to improve unit yield and
Renaud Jacquemart et al.
Computational and structural biotechnology journal, 14, 309-318 (2016-08-30)
The current processing paradigm of large manufacturing facilities dedicated to single product production is no longer an effective approach for best manufacturing practices. Increasing competition for new indications and the launch of biosimilars for the monoclonal antibody market have put
Ying Hou et al.
Biotechnology progress, 31(4), 974-982 (2015-05-29)
Protein A chromatography is widely employed for the capture and purification of monoclonal antibodies (mAbs). Because of the high cost of protein A resins, there is a significant economic driving force to seek new downstream processing strategies. Membrane chromatography has

商品

Membrane adsorbers are a cost-effective, robust, single-use solution for monoclonal antibody polishing

See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

查看所有结果

相关内容

可使用相对模式化的工艺生产活载体疫苗。但挑战依然存在,包括由于无菌过滤、载体聚集和扩大化贴壁培养而导致的产量损失。了解有关该核心平台技术的所有信息,以及如何利用合作增强的专业知识克服生产难题。

A templated process produces live vector vaccines. Challenges: yield loss, filtration, aggregation, scaling. Collaboration overcomes manufacturing hurdles.

病毒疫苗的生产较为复杂,且并无模式化的生产方法。每一道工艺都必须根据病毒的形状、大小、性质、理化行为、稳定性和宿主特异性进行调整。了解有关该核心平台技术的所有信息,以及如何利用合作增强的专业知识克服生产难题。

Tailored viral vaccine manufacturing addresses virus-specific challenges through collaboration.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门